Mar 5, 2026 06:59AM
Mar 3, 2026 05:31PM
Jan 21, 2026 08:30AM
Jan 21, 2026 08:30AM
Jan 20, 2026 07:00AM
Jan 20, 2026 06:59AM
Jan 12, 2026 07:30AM Lexicon Pharmaceuticals Provides a Business and Pipeline Update at the 44th Annual J.P. Morgan Healthcare Conference
Nov 6, 2025 07:30AM
Oct 14, 2025 08:01AM
Oct 14, 2025 08:00AM
Sep 22, 2025 04:00PM
Sep 22, 2025 04:00PM
Sep 11, 2025 06:50AM
Sep 9, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Lexicon Pharmaceuticals (LXRX)
Sep 8, 2025 08:31AM
Sep 8, 2025 08:30AM
Sep 4, 2025 08:30AM
Sep 3, 2025 08:30AM
Sep 2, 2025 08:33AM
Sep 2, 2025 08:30AM
Aug 6, 2025 12:06PM Lexicon Pharmaceuticals (LXRX) PT Raised to $0.85 at Jefferies
Aug 6, 2025 07:30AM
Jul 18, 2025 08:00AM
May 13, 2025 04:00PM
Mar 6, 2025 04:00PM
Mar 3, 2025 07:01AM
Mar 3, 2025 07:00AM
Dec 20, 2024 04:30PM Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)
Nov 26, 2024 08:00AM
Nov 25, 2024 06:39AM
Nov 22, 2024 07:33AM
Nov 22, 2024 07:32AM
Nov 12, 2024 04:05PM
Nov 5, 2024 04:05PM
Nov 4, 2024 08:00AM Lexicon to Present Preclinical IN VIVO Efficacy Data Demonstrating Ability of New Investigational Compound to Enhance and Maintain Semaglutide-Promoted Weight Loss
Nov 1, 2024 07:22AM
Nov 1, 2024 06:40AM
Oct 31, 2024 06:54PM
Oct 22, 2024 08:00AM
Oct 18, 2024 05:48AM
Oct 17, 2024 06:55AM
Oct 16, 2024 04:35PM Lexicon Pharma (LXRX) Announces Exclusive Licensing Agreement With Viatris (VTRS) for Sotagliflozin in All Markets Outside of the U.S. and Europe
Oct 16, 2024 04:35PM
Oct 16, 2024 04:34PM
Sep 27, 2024 08:00AM
Sep 3, 2024 08:00AM
Aug 21, 2024 08:02AM
Aug 21, 2024 08:00AM
Aug 7, 2024 08:00AM Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Disease Among Three Lexicon-Sponsored Presentations at the 2024 Annual Conference of the Association of Di
Aug 1, 2024 04:00PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All